Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.7K

KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath

Zhibin Cui1, Yingjia Shen2, Kenny H Chen1

  • 1Department of Comparative Pathobiology, Purdue University, West Lafayette, Indiana, United States.

Scientific Reports
|January 10, 2017
PubMed

Insights

KANK1 acts as a tumor suppressor gene in malignant peripheral nerve sheath tumors (MPNSTs). Restoring KANK1 inhibits MPNST cell growth by promoting apoptosis, suggesting its potential for targeted cancer therapy.

Area of Science:

  • Oncogenomics
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive sarcomas with limited therapeutic strategies.
  • There is a critical need for novel therapeutic targets in MPNSTs due to their poor prognosis and invasive nature.
  • KANK1 has been identified as a candidate tumor suppressor gene (TSG) in human MPNSTs.

Purpose of the Study:

  • To investigate the role of KANK1 in MPNST tumorigenesis.
  • To elucidate the mechanism by which KANK1 affects MPNST cell growth and apoptosis.
  • To explore the potential of KANK1 as a therapeutic target for MPNSTs.

Main Methods:

  • Comparative oncogenomics to identify candidate TSGs.
  • In vitro studies involving human MPNST cell culture to assess KANK1 restoration and knockdown effects on cell growth and apoptosis.
  • Xenograft mouse models to evaluate KANK1's in vivo efficacy.
  • RNA-sequencing (RNA-seq) analysis to identify downstream targets of KANK1, including CXXC5.
  • Functional assays to confirm the role of CXXC5 in KANK1-mediated apoptosis.

Main Results:

  • Restoration of KANK1 in human MPNST cells significantly inhibited cell proliferation and increased apoptosis in vitro and in vivo.
  • Knockdown of KANK1 in neurofibroma cells promoted cell growth.
  • RNA-seq analysis identified CXXC5 as a KANK1-regulated gene involved in apoptosis.
  • Knockdown of CXXC5 attenuated the apoptosis induced by KANK1 in MPNST cells.

Conclusions:

  • KANK1 functions as a tumor suppressor in human MPNSTs by inhibiting cell growth through CXXC5-mediated apoptosis.
  • KANK1 represents a promising therapeutic target for MPNSTs.
  • Further research into KANK1 and its downstream pathways could lead to novel targeted therapies for MPNST patients.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
701
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K